Inventor · disambiguated record
Chin-Yu Lai
Also filed as: LAI CHIN-YU
3 granted patents·2 pending applications·10 citations·filing 2017–2024
62Inventor score
Files withALLGENESIS BIOTHERAPEUTICS INC5
Top patents by PatentIndex Score
5 records- 0187US10154994B2Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation methods thereofALLGENESIS BIOTHERAPEUTICS INC·Filed 2017·Granted Dec 18, 2018·9 cites·24 claims
- 0279US11369600B2Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation methods thereofALLGENESIS BIOTHERAPEUTICS INC·Filed 2018·Granted Jun 28, 2022·1 cites·15 claims
- 0379US2024408083A1Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation methods thereofALLGENESIS BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0471US2022280506A1Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation methods thereofALLGENESIS BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0557US10961203B2Crystalline forms of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-phenylamino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinoneALLGENESIS BIOTHERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Chin-Yu Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →